Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of SyB D-0701 for Radiotherapy Induced Nausea and Vomiting

NCT01700140 is registered in ClinicalTrials.gov with SymBio Pharmaceuticals as lead sponsor.

NCT NCT01700140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of SyB D-0701 for Radiotherapy Induced Nausea and Vomiting
Lead sponsor
SymBio Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
October 31, 2012
Enrollment
189 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

radiotherapy-induced nausea and vomiting (rinv)